Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 7,566 | 5,124 | 9,032 | 12,000 | 0 |
| Cost of Goods | 2,740 | 746 | 725 | N/A | N/A |
| Gross Profit | 4,826 | 4,378 | 8,307 | 12,000 | N/A |
| Operating Expenses | 71,485 | 70,883 | 30,328 | 42,908 | 40,181 |
| Operating Income | -65,919 | -65,759 | -21,296 | -30,908 | -40,181 |
| Interest Expense | 9,412 | 3,962 | 2,172 | 4,295 | 3,034 |
| Other Income | -1,248 | 2,726 | -1,019 | 123 | 521 |
| Pre-tax Income | -76,579 | -66,995 | -24,487 | -35,080 | -42,694 |
| Net Income Continuous | -76,579 | -66,995 | -24,487 | -35,080 | -42,694 |
| Net Income | $-76,579 | $-66,995 | $-24,487 | $-35,080 | $-42,694 |
| EPS Basic Total Ops | -14.80 | -14.80 | -7.20 | -13.00 | -17.10 |
| EPS Basic Continuous Ops | -14.78 | -14.78 | -7.17 | -12.97 | -17.08 |
| EPS Diluted Total Ops | -14.80 | -14.80 | -7.20 | -13.00 | -17.10 |
| EPS Diluted Continuous Ops | -14.78 | -14.78 | -7.17 | -12.97 | -17.08 |
| EPS Diluted Before Non-Recurring Items | -14.80 | -11.40 | -6.60 | -12.50 | -17.10 |
| EBITDA(a) | $-64,650 | $-64,923 | $-20,470 | $-30,370 | $-39,952 |